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Sixteen ovarian tumor (OTU) family deubiquitinases
(DUBs) exist in humans, and most members regulate
cell-signaling cascades. Several OTU DUBs were
reported to be ubiquitin (Ub) chain linkage specific,
but comprehensive analyses are missing, and the
underlying mechanisms of linkage specificity are
unclear. Using Ub chains of all eight linkage types,
we reveal that most human OTU enzymes are linkage
specific, preferring one, two, or a defined subset of
linkage types, including unstudied atypical Ub
chains. Biochemical analysis and five crystal struc-
tures of OTU DUBs with or without Ub substrates
reveal four mechanisms of linkage specificity. Addi-
tional Ub-binding domains, the ubiquitinated
sequence in the substrate, and defined S1’ and
S2 Ub-binding sites on the OTU domain enable
OTU DUBs to distinguish linkage types. We intro-
duce Ub chain restriction analysis, in which OTU
DUBs are used as restriction enzymes to reveal
linkage type and the relative abundance of Ub chains
on substrates.
INTRODUCTION
Protein ubiquitination is a posttranslational modification of
mostly Lys residues that regulates many cellular processes,
including protein degradation, intracellular trafficking, cell
signaling, autophagy, transcription, translation, and the DNA
damage response (Komander and Rape, 2012). This functional
diversity is achieved by the ability of ubiquitin (Ub) to formtopologically distinct signals. Proteins can be monoubiquiti-
nated at one or multiple sites or polyubiquitinated by modifica-
tion with Ub chains. Within Ub chains, linkages can be formed
via seven Ub Lys residues or via the N-terminal Met1, gener-
ating homotypic (one linkage type per polymer) or heterotypic
(multiple linkage types per polymer) Ub chains (Komander
and Rape, 2012). Differently linked Ub polymers have distinct
cellular functions. Lys48-linked Ub chains serve as a pro-
teasomal degradation signal (Hershko and Ciechanover,
1998), whereas Lys63-linked chains are nondegradative and,
for example, activate protein kinase cascades (Chen and Sun,
2009). Lys11 linkages constitute an alternative degradation
signal used during cell-cycle progression (Wickliffe et al.,
2011). Met1-linked chains cooperate with Lys63 linkages in
NF-kB signaling (Iwai, 2011). For the remaining four Ub chain
types (Lys6, Lys27, Lys29, and Lys33), cellular roles are elusive
(Kulathu and Komander, 2012).
Deubiquitinases (DUBs) remove Ub modifications and regu-
late virtually all Ub-dependent processes (Komander et al.,
2009; Reyes-Turcu et al., 2009). Many of the 80 DUBs that
are predicted to be active in human cells have been implicated
in human diseases such as neurodegeneration, inflammation,
infection, and cancer (Clague et al., 2012). The subfamily
of ovarian tumor (OTU) DUBs have emerged as regulators of
important signaling cascades. A20 (Hymowitz and Wertz,
2010), OTUD7B/Cezanne (Hu et al., 2013) and OTULIN (Keuse-
kotten et al., 2013) regulate NF-kB signaling, OTUD5/DUBA reg-
ulates interferon signaling (Kayagaki et al., 2007), OTUD2/YOD1
and VCPIP regulate p97-mediated processes (Ernst et al., 2009;
Wang et al., 2004), and OTUB1 is involved in the DNA damage
response (Nakada et al., 2010).
Because of the complexity of the Ub modification, DUBs must
display various layers of specificity—they must distinguish not
only between Ub and Ub-like modifications but also betweenCell 154, 169–184, July 3, 2013 ª2013 The Authors 169
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the eight Ub linkage types. Moreover, chain topology and length
may also affect DUB activity (Komander et al., 2009).
The extent to which DUBs are linkage specific is not clear.
Characterized Ub-specific protease (USP) family DUBs are not
linkage specific (Faesen et al., 2011). In contrast, OTU family
DUBs can be linkage specific. OTUB1 prefers Lys48 linkages
(Edelmann et al., 2009; Wang et al., 2009), Cezanne prefers
Lys11 linkages (Bremm et al., 2010), TRABID is Lys29 and
Lys33 specific (Licchesi et al., 2012), and OTULIN is Met1 spe-
cific (Keusekotten et al., 2013). However, with the exception of
TRABID and OTULIN, comprehensive analyses comparing all
chain types have not been performed.
Here, we provide a biochemical characterization of all 16
human OTU DUBs that contain a complete catalytic triad
and analyze their cross-reactivity against Ub-like molecules,
catalytic activity, and linkage specificity. Most OTU DUBs
show intrinsic linkage specificity, preferring one or a small
defined subset of Ub linkage types. Mechanistic and structural
studies of three closely related, unstudied OTUs with distinct
cleavage profiles revealed four mechanisms for achieving
linkage specificity, namely (1) the use of additional Ub-binding
domains (UBDs), (2) specific recognition of a ubiquitinated
sequence, (3) the use of a conserved S1’ Ub-binding site on
the OTU domain itself, and (4) the use of an S2 site enabling
DUBs to bind longer chains in a linkage-specific manner. The
linkage specificity in OTU DUBs can be exploited in Ub chain
restriction analysis, whereby linkage-specific DUBs are used
to identify the linkage type(s) on a ubiquitinated protein.
RESULTS
The Human OTU Enzymes
In the human genome, OTU domains exist in at least 18 genes,
14 of which have been annotated as active DUBs (Komander
et al., 2009). In addition to these, OTULIN/FAM105B (Keusekot-
ten et al., 2013) and ALG13 (UniProt Q9NP73) have recently been
described or annotated as additional OTU domains with a com-
plete catalytic triad. FAM105A (UniProt Q9NUU6) contains an
OTULIN-like OTU domain but lacks catalytic triad residues.
HIN1L is a pseudogene (http://www.ncbi.nlm.nih.gov/gene/
360227). Phylogenetic analysis delineates four subfamilies:
the OTUB subfamily/Otubains (OTUB1 and OTUB2), the OTUD
subfamily (OTUD1, OTUD2/YOD1, OTUD3, OTUD4, OTUD5/
DUBA, OTUD6A, OTUD6B, ALG13, and HIN1L), the A20-like
subfamily (A20, Cezanne, Cezanne2, TRABID, and VCPIP), and
the OTULIN subfamily (OTULIN and FAM105A) (Figure 1A). The
size of the catalytic domain distinguishes subfamilies—OTUD
enzymes being the smallest (150 amino acids [aa]), and theFigure 1. Human OTU DUBs and Reactivity of Analyzed Constructs
(A) Phylogenetic tree of human OTU domain DUBs. HIN1L (*) is a pseudogene, a
(B) Domain composition in human OTU DUBs (updated from Komander et al. [20
(C) Constructs analyzed in this study. Full-length proteins not used in this study
(D) Purified OTU proteins according to (C) resolved on a Coomassie-stained
constructs.
(E) Reactivity of analyzed constructs against the suicide probe Ub propargylam
indicate the modified form of the OTU DUB.
See also Figure S1.OTUB/OTULIN (220–270 aa) and A20-like OTUs (300–350 aa)
containing larger catalytic folds. Most human OTUs contain
additional domains, including UBDs (Figure 1B).
We cloned the 16 catalytic-triad-containing human OTU
DUBs from plasmids, IMAGE clones, or human complementary
DNA (cDNA) libraries and expressed and purified full-length
(FL) and/or OTU domain-containing constructs in E. coli
(Figures 1C and 1D). Most OTUs reacted quantitatively with Ub
propargylamide (Ub-PA) (Ekkebus et al., 2013), indicating proper
folding and a reactive catalytic Cys (Figure 1E, Figure S1A avail-
able online). OTUD5/DUBA required activation by phosphoryla-
tion in the OTU domain by recombinant CK2 to display reactivity
(Huang et al., 2012). OTULIN did not react with Ub-PA because it
requires activation by a proximal Ub for activity (Keusekotten
et al., 2013). ALG13 did not react with Ub-PA, but it did react
with haloalkyl probes, and A20 reacted very slowly and incom-
pletely with all tested probes (Figures 1E, S1A, and S1B).
The C terminus of Ub is important for DUB reactivity (Drag
et al., 2008). The Ub-like modifiers ISG15 and NEDD8 have
identical or similar C-terminal sequences, and whereas OTUB1
is Ub specific (Edelmann et al., 2009), viral OTU domains
(vOTU) can be cross-reactive for Ub and ISG15 (Frias-Staheli
et al., 2007). We found that ISG15-based suicide probes that
modified vOTU (Akutsu et al., 2011) did not react with human
OTU DUBs (Figure S1C). In contrast, 13 of the 16 human OTU
DUBs were modified by NEDD8-derived suicide probes to
varying degrees (Figure S1D). However, comparing Ub- and
NEDD8-based peptide substrates in fluorescence polarization
assays (Geurink et al., 2012) (see below) showed that OTU
DUBs only hydrolyzed the Ub-based, but not the NEDD8-based,
substrates under identical conditions (Figure S1E), indicating
that human OTU DUBs are Ub specific.
Linkage Specificity of OTU DUBs against Diubiquitin
Next, we analyzed the linkage specificity of human OTU DUBs
against all eight types of diubiquitin (diUb) (Figure 2A). Time-
course experiments were performed at constant substrate
concentration. Enzymes were used at different concentrations
in order to identify the lowest DUB concentration that resulted
in significant cleavage of the preferred chain type(s), indicating
linkage preference of the DUB.
The results of this analysis revealed a striking and unexpected
linkage specificity of all human OTU DUBs (Figure 2A). Six DUBs
(Cezanne, Cezanne2 – Lys11; OTUD4, OTUB1 – Lys48; OTUD1 –
Lys63; OTULIN – Met1) cleaved only one diUb substrate
(group I), four DUBs (OTUD3 – Lys6 and Lys11; A20, VCPIP –
Lys11 and Lys48; phosphorylated OTUD5 – Lys48 and Lys63)
cleaved two substrates (group II), and four DUBs (OTUD2,nd FAM105A (**) is lacking active site residues.
09]).
are shown in gray.
4%–12% SDS-PAGE gradient gel. M, marker. Asterisks (*) indicate purified
ide (Ub-PA, upper panel) and Cy5-labeled Ub-PA (lower panel). Asterisks (*)
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Figure 2. Linkage Specificity of Human OTU DUBs
(A) Purified OTU DUBs (constructs according to Figure 1C) were incubated with diUb of all linkage types for the indicated times and resolved on silver-stained
SDS-PAGE gradient gels. Enzyme concentration is as indicated and differs for each DUB. See Figure S2 for additional experiments.
(B) OTUDUB linkage specificity against diUb substrates can be grouped to enzymes cleaving one linkage type (group I), two linkage types (group II), three ormore
linkage types (group III), or inactive enzymes (group IV).OTUD6A, OTUB2, TRABID) cleaved three or more chains prefer-
entially (group III) (Figures 2A and 2B). ALG13, unphosphorylated
OTUD5, and OTUD6B were inactive in this assay (group IV)
despite being modified by Ub suicide probes (Figures 1E, S1A,
and S1B).
Increasing the concentration of DUB in the assay or using
longer incubation times led to the hydrolysis of linkages other172 Cell 154, 169–184, July 3, 2013 ª2013 The Authorsthan the preferred linkage types (Figure S2). With the exception
of OTULIN, no tested DUB hydrolyzed Met1 linkages even at a
higher enzyme concentration or later time points (Keusekotten
et al., 2013), suggesting that OTU DUBs are mostly isopepti-
dases. The OTU DUB cleavage profiles differed from USP
domain DUBs that cleave all types of diUb with similar activity
(Faesen et al., 2011).
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Figure 3. Roles for UBDs in OTU Specificity
(A) Surface representation of an OTU domain (blue) bound to a distal Ub molecule (yellow) with its C terminus reaching to the active site. The proximal Ub in the
dimer needs to bind such that only the preferred linkage point(s) (indicated in red on Ub surface) are presented to the active site.
(B) DUB assays performed as in Figure 2A with OTUD1 aa 287–481 (OTU+UIM, top) and 287–437 (OTU, bottom). The construct lacking the UIM domain is
nonspecific and less active (14.53 higher enzyme concentration used in gel below).
(C) Specificity analysis of different OTUD2 constructs. Top, OTUD2 lacking the UBX-like domain. Second from top, OTUD2 lacking the ZnF domain. Third from
top, OTUD2 isolated OTU domain. Bottom, OTUD2 with a mutation in the ZnF domain. The ZnF affects the ability of OTUD2 to cleave Lys27-, Lys29-, and Lys33-
linked diUb. See Figure S3 for additional experiments.
(D) Specificity assays of OTUD3 for constructs including the OTU and UBA domains (top) and the catalytic domain alone (bottom). The UBA domain has no
influence on diUb hydrolysis.
(E) Mechanism 1, positioning and orientation of the proximal Ub is achieved by its binding to a UBD present in the OTU enzyme.
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It was unclear whether OTU orthologs have conserved
their linkage preference throughout evolution. S. cerevisiae
encode only two OTU DUBs, yOtu1 and yOtu2. yOtu1 and
D. melanogaster (dm) Otu1 are orthologs of human OTUD2
(38% and 53% identical in OTU domain, respectively), and
OTUD2 and yOtu1 both bind cdc48/p97 and are involved in
endoplasmic-reticulum-associated protein degradation (Ernst
et al., 2009; Rumpf and Jentsch, 2006). OTUD2 and yOtu1
preferred the same atypical linkages (Figures 2A and S2D),
whereas dmOtu1 also cleaved Lys6 linkages, indicating that
the linkage profiles of OTU enzymes are not necessarily identical
in different species (Figure S2E).
Altogether, this revealed that the OTU family had evolved
enzymes that recognize and hydrolyze specific Ub chain types.
Mechanisms of Linkage Specificity
Distinct Ub linkage specificity in members from a single DUB
family was unexpected and required a mechanistic explanation.
During the hydrolysis of diUb, both Ub moieties interact with the
DUB’s catalytic domain (Figure 3A). The distal Ub moiety binds
to the enzymatic S1 site and positions its C-terminal tail in the
catalytic site. This distal Ub is identical in each diUb molecule
and does not explain linkage specificity. In contrast, the proximal
Ub moiety that binds to the enzymatic S1’ site contributes the
Lys to the isopeptide bond. Hence, mechanisms to position
and orient the proximal Ubmoiety are the key to understand link-
age specificity in DUBs.
We selected three members of the OTUD family for additional
investigation: the unstudied Lys63-specific OTUD1, the cdc48/
p97 interactor OTUD2 that cleaves atypical linkages (Lys11,
Lys27, Lys29, and Lys33), and OTUD3, another unstudied DUB
with activity against Lys6- and Lys11-linked diUb (Figure 2A).
Roles for UBDs in Linkage Specificity
First, we tested whether UBDs in OTUDs contribute to posi-
tioning the proximal Ub toward the catalytic center. OTUD1
contains a C-terminal Ub-interacting motif (UIM, aa 457–476),
OTUD2 contains an UBX-like domain (aa 46–128) and a C-termi-
nal zinc finger (ZnF, aa 318–342), and OTUD3 contains a C-ter-
minal Ub-associated domain (UBA, aa 230–270). We compared
the activity and linkage specificity for truncated OTUD enzymes
(Figure 3).
The removal of the OTUD1 UIM had dramatic effects on activ-
ity and linkage specificity. Full-length OTUD1 or a construct
comprising OTU and UIM were highly active and Lys63 specificFigure 4. Linkage Specificity Determinants in the Proximal Ub
(A) Schematic representation (left) and sequence of generated fluorescent ubiqu
TAMRA refers to the fluorescent group appended to the N terminus of the peptid
(B–E) OTUD1 (B), OTUD3 (C), and OTUD2 (D and E) used at the different concentr
(B) andOTUD3 (C) (as well as OTUB1 andCezanne2, see Figure S4) hydrolyzedmo
requirement for other regions in the proximal Ub to recover specificity. OTUD2 hy
highest activity against the K6 and K11 peptide that were already hydrolyzed at th
revealed that the enzyme was sequence specific for a ubiquitinated peptide bas
(F) Alanine scanning mutagenesis of the K11 peptide and assay with OTUD2 at 1
except F4A. Residues affecting OTUD2-mediated hydrolysis are indicated in red i
the difference in sequence specificity between these similar peptides. Mutation o
also Figure S4.
(G) Mechanism 2, OTUD2 is able to read the sequence context of the ubiquitinat(Figures 2A and 3B). The removal of the UIM in the OTU-only
construct rendered the protein less active (assay performed at
a 14.53 higher enzyme concentration) and, importantly, nonspe-
cific (Figure 3B). Hence, in OTUD1, the UIM greatly increased the
specificity and efficiency of the enzyme toward Lys63 linkages.
This is similar to TRABID, where an N-terminal ankyrin-repeat
Ub-binding domain is required for Lys29 and Lys33 linkage
specificity (Licchesi et al., 2012).
Full-length OTUD2 cleaved Lys11-, Lys27-, Lys29-, and
Lys33-linked diUb (Figure 2A). Removal of the N-terminal UBX-
like domain did not affect OTUD2 specificity, but deletion of
the C-terminal ZnF domain or point mutations in zinc-binding
residues significantly reduced activity toward Lys27-, Lys29-,
and Lys33-linked diUb without affecting Lys11 activity (Fig-
ure 3C). The samewas observed in dmOtu1 (Figure S3A). Hence,
the ZnF domain in OTUD2 enabled a Lys11-specific catalytic
core domain to cleave three additional linkage types. This sug-
gested that the OTUD2 ZnF is a UBD; however, we were unable
to detect an interaction with monoUb in nuclear magnetic reso-
nance (NMR) chemical shift perturbation experiments (Figures
S3B–S3E). UBDs do not always influence linkage specificity, at
least for diUb substrates, as shown for OTUD3, where the
removal of the UBA domain did not change its ability to cleave
Lys6- and Lys11-linked diUb (Figure 3D).
Hence, additional domains can both restrict and broaden the
linkage specificity profile of OTU DUBs and fulfill important roles
in regulating OTU activity and linkage specificity (Figure 3E).
Notably, 8 of the 16 humanOTUDUBs contain UBDs (Figure 1B),
suggesting that this could be a widely used mechanism. More-
over, UBDs in DUBs of other families (USPs and Josephins)
could have similar roles.
Sequence Specificity in OTU Domain DUBs
Isolated catalytic OTU domains showed distinct linkage speci-
ficity against diUb substrates (Figures 3B–3D), and, next, we
investigatedwhether the entire proximal Ub or only the sequence
surrounding the ubiquitinated Lys was important for linkage
specificity. For this, fluorescent ubiquitinated 14-mer peptides
derived from Ub (Figure 4A) (Geurink et al., 2012), as well as a
minimal fluorescent Lys-Gly (KG) peptide, were used in fluores-
cence anisotropy assays at fixed substrate and increasing OTU
DUB concentrations (Figures 4 and S4).
In themajority of OTUDUBs tested, the peptide probes did not
reflect the linkage specificity seen with diUb. OTUD1, OTUD3,
OTUB1, and Cezanne2 hydrolyzed most or all peptideitinated Ub peptides. The red K indicates the ubiquitination site in the peptide.
e.
ations (indicated to the right) cleaved the indicated peptides over time. OTUD1
st of or all the peptides similarly, indicating a lack of sequence preference and a
drolyzed all peptides if used at high enzyme concentrations (D) yet showed the
e start of the measurement. Dilution of OTUD2 to picomolar concentrations (E)
ed on the Ub Lys11 context.
nM concentration as performed in (E). The y axis scale is the same in all graphs
n the sequence alignment (right). Leu15, not present in the K6 peptide, explains
f Lys6 to Ala resulted in an insoluble peptide, and Gly10 was not mutated. See
ion site, bind, and cleave in a sequence-specific fashion.
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substrates (Figures 4B, 4C, S4A, and S4B), albeit with reduced
activity for some combinations (e.g., OTUD1 against K33 pep-
tide, Figure 4B). This suggested that the recognition of the entire
proximal Ub fold is required for the linkage specificity of these
DUBs, which was consistent with the involvement of, for
example, UBDs (Figure 3).
In contrast, and to our surprise, OTUD2 displayed a marked
specificity for the peptide that was derived from the Lys11
sequence of Ub (K11 peptide, Figures 4D and 4E). OTUD2
hydrolyzed all peptide substrates at a high enzyme concentra-
tion but had already completely hydrolyzed the K11 peptide at
the start of the measurement (Figure 4D). Dilution of OTUD2 to
picomolar concentrations recovered complete specificity of the
DUB against the K11 peptide, and even the similar K6 peptide
was not hydrolyzed significantly at low enzyme concentrations
(Figure 4E). To further understand this, we mutated each amino
acid of the ubiquitinated K11 peptide to Ala (Figure S4C). The
K6A peptide was insoluble, and Gly10 was not mutated. Exper-
iments performed at an OTUD2 concentration that cleaved
the K11 peptide revealed that Ala substitutions of Phe4, Val5,
Thr7, Leu8, Thr12, Ile13, and Leu15 significantly reduced the
hydrolysis activity of the peptide (Figures 4F and S4D). Several
of these residues are solvent exposed in Ub, suggesting that
OTUD2 binds to these residues of the proximal Ub. However,
Ile13 and Leu15 are not exposed in folded Ub and, hence, are
unlikely to play a role in diUb recognition.
Nonetheless, this revealed another mechanism of OTU DUB
linkage specificity whereby OTUD2 selected the sequence
context of a ubiquitinated substrate, in this case recognizing
the Ub sequence surrounding Lys11 (Figure 4G).
Structural Studies on OTUD Family DUBs
To understand the specificity of OTUD domains at the molecular
level, we determined high-resolution crystal structures of OTUD1
(aa 287–437, 2.1 A˚, Figures 5A and S5A), OTUD2 (aa 132–314,
1.5 A˚, Figures 5B and S5B), and OTUD3 (aa 52–209, 1.55 A˚, Fig-
ures 5C and S5C) (Table S1). The catalytic domains are structur-
ally similar to each other and to OTUD5 (Huang et al., 2012) and
S. cerevisiae Otu1 (yOtu1) (Messick et al., 2008), root-mean-
square deviations (rmsds) being from 0.6–1.0 A˚ (Figure S5D).Figure 5. Structural Studies on OTUD1, OTUD2, and OTUD3 Reveal a C
(A–C) Crystal structures of the OTU domains of OTUD1 (A), OTUD2 (B), and
S1 Ub-binding site, N and C termini, and N- or C-terminal a helix are labeled.
(D) Structure of inactive OTUD2 catalytic domain (C160A) in complex with the ubiq
enzyme (boxed) shown as in (B). The inset shows a stick model of the ubiquitina
(E–G) Surface residues of OTUD1 (E), OTUD2 (F), and OTUD3 (G) are colored acc
alignments in Data S1).
(H) Top view of the putative S1’ site in OTUD2. The peptide structure in (D) reveals h
V loops as well as the C-terminal helix are indicated.
(I) Putative S1’ site in the structure of OTUD2 bound to the ubiquitinated K11 pe
(J) The same view as in (I) for the OTUB1 structure with two Ubmoieties bound in S
loops and also a dedicated S1’ binding site in a protruding N-terminal helix uniq
(K) Superposition of (I) and (J) showing the compatibility of S1’ binding sites.
(L) Sequence of Cys, His, and V loops in the humanOTUD enzymes, yOtu1, and dm
asterisk (*) indicates catalytic Cys or His.
(M) A His loop mutation in OTUD3, R178YGE to LSNG, creates a less active OTUD
activity (see also Figure S5K). Note the differences in enzyme concentration use
(N) Mechanism 3, a conserved S1’ Ub-binding site on OTU DUBs positions the p
See also Figure S5.Catalytic triads are in competent conformations, as observed
for pOTUD5 in complex with a Ub suicide probe (Huang et al.,
2012) (Figures S5D and S5E).
Furthermore, we determined the structure of OTUD2 bound to
the ubiquitinated K11 peptide (Figure 5D), representing the first
structure of an OTU with an isopeptide bond spanning the active
site. Clear electron density for the isopeptide bond (Figure S5F)
and for four residues upstream and two residues downstream of
the ubiquitinated Lys revealed how the scissile bond reaches
across the active site. Unfortunately, the close packing of a
symmetry-related molecule (Figure S5G) most likely affects the
position of the peptide, and residues that affect K11 peptide
hydrolysis (Phe4, Val5, and Leu15) (Figures 4F and S4D) are
disordered in the structure. The peptide does not form significant
contacts with the protein, which would have been expected from
the peptide assay, suggesting that crystal lattice formation
affects peptide binding.
The Ub in the OTUD2 K11 peptide structure is located at a
similar position in the S1 site of the enzyme in comparison
to structures of OTUDs with Ub-based suicide inhibitors (Huang
et al., 2012; Messick et al., 2008) (Figures 5D and S5E). OTUD5,
but not yOtu1, requires activation by phosphorylation in the OTU
domain, which leads to the formation of the S1 Ub-binding site
(Huang et al., 2012) (Figure S5E). In OTUD1, OTUD2, and
OTUD3, the corresponding secondary structure elements are
present with or without Ub bound (Figure S5D), and there are
no large-scale conformational changes in OTUD2 upon Ub
binding (Figures 5B and 5D).
Conserved and Distinct OTU Domain S1’ Ub-Binding
Sites
The K11 peptide structure revealed how the isopeptide bond is
bound by OTU domains and how the proximal Ub is contacted
to form an S1’ substrate-binding site on OTUD DUBs. The Lys
side chain approaches the catalytic center across the loop pre-
ceding the catalytic Cys, termed the Cys loop (Figures 5H, 5I,
and S5H). The neighboring His loop connects the catalytic
His with a conserved upstream aromatic residue that forms
interactions with the C terminus of the distal Ub. A third loop,
the variable loop (V loop), located opposite to the His looponserved S1’ Site
OTUD3 (C). A cartoon representation in identical orientation is shown. The
uitinated K11 peptide (orange, see Figure 4) bound across the active site of the
ted peptide.
ording to conservation of the protein throughout evolution (on the basis of the
ow the isopeptide is bound across the active site of anOTUDUB. Cys, His, and
ptide. An arrow indicates the scissile bond.
1 and S1’ sites (Wiener et al., 2012). The proximal Ub contacts the Cys and His
ue to OTUB1.
Otu1. Residues in red are ‘‘anchor’’ points of conserved structural residues. An
3 variant in which Lys11-diUb activity is more strongly affected than Lys6-diUb
d in the assays.
roximal Ub toward the catalytic center.
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may also contact the proximal Ub. Along with these loops, the
N-terminal helix in the OTUD1 and OTUD3 catalytic domain
and the structurally equivalent C-terminal helix of the OTUD2
catalytic domain form the putative S1’ site that binds the
proximal Ub (Figures 5H, 5I, and S5H). In recent complex
structures of OTUB1 with Ub bound in the S1’ site of the DUB
(Juang et al., 2012; Wiener et al., 2012) and of OTULIN bound
to Met1-linked diUb (Keusekotten et al., 2013), additional
N-terminal helices form extensive S1’ sites (Figures 5J, 5K,
S5I, and S5J). These are not present in minimal OTUD domains
(Figures 5I and S5H).
When the sequence conservation of OTUD orthologs from
species annotated in the Ensembl project (www.ensembl.org;
Data S1) is mapped onto the surface of OTUD1, OTUD2, and
OTUD3, the putative S1’ site comprising Cys and His loops
emerged as regions of highest surface conservation greater
than the S1 Ub-binding site (Figures 5E–5G). Importantly, the
amino acid sequence in the loops varies significantly between
OTUD family members, in particular in the His and V loops (Fig-
ure 5L), indicating changes that may account for the observed
differences in linkage specificity.
We wondered whether mutations in the His and Cys loops
would change the cleavage profile of OTUD DUBs. Substitution
of the His loop of OTUD3 by the corresponding sequence in
OTUD1 (mutating R178YGE to LSNG) rendered the protein signif-
icantly less active in comparison to the wild-type (WT) enzyme
and affected its ability to target Lys11-linked, but not Lys6-
linked, diUb, even at very high concentrations (Figures 5M and
S5K). Hence, we engineered anOTU domain with a unique spec-
ificity profile against diUb.
Altogether, the structural and mutagenesis data revealed
distinct S1’ Ub-binding sites on OTUD family enzymes that
contribute to their ability to target selected Ub linkages (Fig-
ure 5N). However, complex structures with diUb bound across
the active site are required to fully understand OTUD specificity
and to rationally design enzymes with new properties.
An S2 Site in OTUD2 Enables Specificity for Longer
Lys11-Linked Chains
Our attempts to generate substrate-bound OTUD structures
revealed an additional mechanism of specificity for OTUD2. In
a structure of inactive OTUD2 C160A in complex with Lys11-
linked diUb, the diUb molecule did not bind across the active
site but occupied S1 and a previously unidentified S2 site on
OTUD2 (Figure 6A). The S2 site is formed by two exposed hydro-
phobic residues (Ile292 and Val295) on the C-terminal OTUD2
a helix that bind the hydrophobic Ile44 patch of Ub (Figure 6B).
The orientation of Ub bound to the S2 site most likely allows pref-
erential binding of Lys11-polyUb, given that the S2 Ub points
with its C terminus toward Lys11 of the S1 Ub (Figure 6A). Inter-
estingly, in the structure of OTUD2 C160A bound to the ubiquiti-
nated K11 peptide (Figure 5D), a second Ub in the asymmetric
unit occupied the S2 site in an identical manner (Figure 6C).
The S2 site in OTUD2 is conserved in higher eukaryotes but
not in yOtu1 and dmOtu1 (Figure 6B and Data S1).
We tested whether the S2 site was functionally relevant in iso-
lated catalytic domains of OTUD2 variants and mutated Ile292
and Val295 to Gln (referred to as OTUD2 MutS2), which did not178 Cell 154, 169–184, July 3, 2013 ª2013 The Authorsaffect reactivity or diUb specificity (Figures S6A and S6B).
Next, we compared the activity of the OTU domains of OTUD2,
OTUD2 MutS2, and dmOtu1 toward Lys11-linked chains. All
proteins hydrolyzed Lys11-diUb similarly, but Lys11-linked tri-
and tetra-Ub were more rapidly cleaved to di- and mono-Ub
by WT OTUD2, whereas OTUD2 MutS2 or dmOtu1 did not
show enhanced activity for longer Lys11-linked chains (Figures
6D and S6C). The accumulation of Lys11-linked diUb indicated
that this product might be stabilized by binding the S1 and S2
sites on OTUD2, as was observed in the complex structures,
although OTUD2 MutS2 did not show enhanced diUb cleavage.
The S2 site specifically enhanced the cleavage of Lys11-linked
polyUb, given that Lys6-, Lys48-, or Lys63-linked triUb were
less well hydrolyzed by WT OTUD2 in comparison to MutS2 or
were not hydrolyzed at all (Figures 6E and S6D). OTUD1 does
not provide a structurally equivalent hydrophobic S2 site on
its a1 helix and is not enhanced in cleaving longer chains
(Figure S6E).
Hence the presence of an S2 site on the OTUD2 catalytic
domain allows it to specifically target longer Lys11-linked chains,
revealing an additional mechanism of OTU specificity (Figure 6F).
Linkage-Specific OTU DUBs Enable the
Characterization of polyUb Chains
Biochemical tools that allow the identification of the Ub chain
type on a substrate are limited. Mass spectrometry, linkage-spe-
cific antibodies, Ub chain sensors, and Ub mutants have been
used to determine Ub chain type and topology, but all these
methods have limitations (Kulathu and Komander, 2012;William-
son et al., 2013).
We tested whether linkage-specific OTU DUBs could be used
in analogy to DNA restriction enzymes to hydrolyze specific link-
ages in complex samples to reveal the linkage type(s) present in
a ubiquitinated substrate. In combination, OTU DUBs can be
used to examine most linkage types (Figures 2 and 7A).
Using linkage-specific assembly systems, we generated
Lys63-, Lys48-, Lys11- and Met1-polyubiquitinated model
substrates in vitro, (see Experimental Procedures), which were
treated with a panel of DUBs (Figures 7A–7G and S6F–S6H).
Under these conditions, the nonspecific enzyme USP21 (Ye
et al., 2011) hydrolyzed most or all ubiquitin linkages, whereas
the nonspecific vOTU DUB (Akutsu et al., 2011) efficiently
removed all isopeptide-linked polyUb.
Linkage-specific OTU DUBs were used at a low concentration
in order to maximize DUB specificity, and they were also used at
a 33–103 higher concentration in order to drive preferred reac-
tions to completion (Figure 7B). DUB-treated samples were
resolved on SDS-PAGE gradient gels and analyzed by silver
staining and/or western blotting. Three parameters indicated
that DUBs affected the substrate: (1) the reduction of high-
molecular-weight (HMW) polyUb, (2) the emergence of monoUb,
and (3) the appearance of free chains released from HMW
species.
The OTU DUBs cleaved polyUb substrates according to their
specificity profiles. OTUD1 reduced Lys63-polyUb to monoUb
(Figures 7C, 7D, S6F, and S6G), and OTUB1 generated monoUb
from E6AP-assembled Lys48-polyUb (Figures 7E and S6H).
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Figure 6. Complex Structures of OTUD2 Reveal an S2 Ub-Binding Site
(A) Structure of the inactive OTUD2 OTU domain (C160A) bound to Lys11-linked diUb in the S1 and S2 site of the enzyme. The orientation of the Ub molecules is
compatible with Lys11 linkage, although the linker sequence is not resolved in the electron density maps (indicated by arrows).
(B) Close-up image of the hydrophobic S2 site on the a6 helix formed by Ile292 and Val295, which interact with the Ile44 patch of Ub. An alignment shows
conservation of this sequence in different species (see also Data S1).
(C) Structure of inactive OTUD2 in complex with the ubiquitinated K11 peptide as in Figure 5D. A second Ub for which the peptide is disordered is bound in the S2
site (see Figure S5G).
(D) DUB assays with Lys11-linked Ub chains. Assays comparing isolated catalytic domains of WT OTUD2 (aa 147–314) and S2 site mutant (MutS2, aa 147–314,
I292Q, V295Q) as well as dmOtu1 (aa 143–313) toward Lys11-diUb (top), Lys11-triUb (middle), and Lys11-tetraUb (bottom). Human OTUD2 hydrolyzed tri- and
tetra-Ub immediately, and this depended on the S2 site of the enzyme.
(E) Cleavage of differently linked triUb chains. In comparison to (D) and Figure 2A, a 4-fold lower enzyme concentration was used.
(F) Mechanism 4, an S2 Ub-binding site on OTU DUBs allows the DUB to target and specifically hydrolyze longer Ub chains.
See also Figures S6A–S6E.Lys11-linked chains, and diUb accumulated in OTUD2-treated
samples (Figure 7F). Only OTULIN hydrolyzed HOIP-assembled
Met1-linked chains (Figure 7G).Interestingly, in some cases, OTUD DUBs released intact
polyUb chains from substrates (Figures 7C–7E and S6F–S6H).
This could be due to the presence of chain types other thanCell 154, 169–184, July 3, 2013 ª2013 The Authors 179
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Figure 7. Exploiting OTU DUBs in Ub Chain Restriction Analysis
(A) Schematic of the principle of Ub chain restriction analysis.
(B–I) Ub chain restriction analysis against the indicated substrates. SDS-PAGEgradient gels were silver-stained (B–E, G, andH) or western blottedwith anti-Ub (F)
or anti-RIP1 (I). M, marker; Control, ubiquitinated protein without DUB treatment. Enzyme bands are highlighted in silver-stained gels (green boxes).
(B) Enzyme input reference gel.
(C) GST-TRAF6, UBE2N, and UEV1A generated free and attached Lys63-linked polyUb. See Figure S6F for an anti-Ub western blot of this gel.
(legend continued on next page)
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the preferred chain types in assembly reactions, cleavage of the
isopeptide linkage between substrate and Ub chain, or the hy-
drolysis of branched Ub polymers. Importantly, released intact
polyUb chains could still be used to identify chain types, given
that differently linked polyUb chains have distinct electro-
phoretic mobility. OTUD2 released chains from GST-tagged
NEDD4 and E6AP, which showed identical electrophoretic
mobility to free Lys48- or Lys63-linked polymers, respectively
(Figure 7H). A double band for triUb observed in a OTUD2-
treated UBE2S sample indicated small amounts of Lys63 link-
ages in the reaction, as reported previously (Bremm et al., 2010).
In the case of GST-E6AP, DUB treatment was inefficient, and
HMW species remained, even at high concentration of DUBs
(Figure 7E). This is consistent with recent data showing that
longer Lys48 chains may be more resistant to DUB hydrolysis
(Schaefer and Morgan, 2011; Ye et al., 2012).
Altogether, our data showed that OTU DUBs maintained their
specificity when tested against polyubiquitinated substrates.
To test their action against endogenously ubiquitinated sub-
strates, we purified the TNF receptor signaling complex (TNF-
RSC) using FLAG-tagged TNFa. The TNF-RSC contains many
ubiquitinated proteins, including RIP1, which can be detected
by western blotting with an antibody against RIP1 (Figure 7I)
and was previously shown to be modified with at least four
different Ub chain types (Gerlach et al., 2011). When treated
with the DUB panel, OTUD1 substantially reduced HMW forms
of RIP1, suggesting the prevalence of Lys63 linkages on RIP1.
OTUD2 was also able to reduce the polyUb RIP1 signal, but, in
this experiment, it cannot be assessed whether OTUD2 also
released polyUb chains. In comparison, Cezanne, OTUB1, and
OTULIN treatment did not lead to a strong reduction of the
polyUb signal (Figure 7I), suggesting that Lys11-, Lys48-, and
Met1-linked chains only account for a small fraction of the total
linkages in RIP1.
Altogether, these experiments showed that OTU DUBs can be
used to interrogate the type and relative abundance of Ub chains
on substrates. We believe that Ub chain restriction analysis will
be a useful tool in Ub chain research.
DISCUSSION
OTUs: A Remarkable DUB Family
Deubiquitinases are the subject of intense research, and many
are intimately linked to human disease. Here, we characterized
the second largest human family of DUB enzymes biochemically
and structurally to discover that individual OTU DUBs have
evolved distinct Ub linkage specificities. This finding is in
contrast to USP DUBs, which cleave most Ub chain types indis-
criminately (Faesen et al., 2011) and to JAMM family enzymes,
many of which are Lys63 specific (Cooper et al., 2009). This
insight immediately suggests that OTU DUBs may be less spe-(D) Lys63-autoubiquitinated GST-tagged NEDD4 HECT domain with UBE2L3. S
(E) Lys48-autoubiquitinated GST-E6AP with UBE2L3. See also Figure S6H.
(F) Lys11-autoubiquitinated UBE2S containing contaminating Lys63 linkages (Br
(G) Met1-linked polyUb generated by a minimal HOIP construct with UBE2L3.
(H) OTUD2 released polyUb chains from GST-E6AP and GST-NEDD4 compared
(I) Ub chain restriction analysis of polyubiquitinated RIP1 generated by FLAG-TNFcific to the ubiquitinated protein per se and that their role is to
regulate the abundance of selected Ub chain types that may
arise under certain physiological conditions.
Four Mechanisms of Ub Linkage Specificity
We identify four distinct mechanisms of how OTU DUBs achieve
linkage specificity. Of these mechanisms, two rely on proper
positioning of the proximal Ub, which is achieved by either addi-
tional UBDs or an S1’ Ub-binding site on the OTU domain itself.
Future structural studies of DUB polyUb complexes may allow
DUB specificity engineering to generate enzymes with improved
specificity, which would be beneficial for Ub chain restriction
analysis and deeper understanding Ub chain biology.
Furthermore, we found that most OTUDUBs hydrolyze ubiqui-
tinated Ub-derived peptides nonspecifically, indicating that an
intact proximal Ub is required for their linkage specificities, which
is consistent with aforementioned mechanisms. Interestingly,
OTUD2 was highly selective for a ubiquitinated peptide derived
from the Lys11 context of Ub, and an Ala scan revealed the res-
idues involved in this specificity. Some of these residues (Ile13
and Leu15) are not exposed in Ub and do not explain the
observed chain specificity but indicate that hydrophobic
patches are most likely involved in proximal Ub recognition.
The identification of a seemingly sequence-specific DUB fuels
an ongoing debate on sequence specificity in protein ubiquitina-
tion. Global proteomic studies indicate a lack of sequence pref-
erence in protein ubiquitination sites (Kim et al., 2011; Wagner
et al., 2011), and current models suggest that E3 ligases target
a ‘‘ubiquitination zone’’ on substrates to modify accessible Lys
residues within reach of the E3 ligase. However, the anaphase
promoting complex (APC/C) preferentially ubiquitinates an initia-
tion motif in its substrates (Williamson et al., 2011), suggesting
that ubiquitination may, in some cases, be sequence specific.
Our structural studies of Ub and diUb complexes for OTUD2
unexpectedly revealed another mechanism that targets OTUD2
to longer Ub chains. Both complex structures uncovered an S2
site on the OTU domain itself, and our functional studies indicate
that this site provides a mechanism for enhancing activity, and
therefore specificity, toward longer K11-linked Ub chains. It is
possible that the UBDs in other OTU DUBs (and in other DUB
families), may serve similar roles in targeting the enzymes to
polyUb-modified substrates. These four mechanisms, along
with the mechanism of substrate-assisted catalysis in OTULIN
(Keusekotten et al., 2013), provide a basis for understanding
linkage specificity in DUBs.
Physiological Questions Arising
Many members of the OTU family have remained relatively
unstudied. The best-studied OTU enzymes are the Ub-chain-
editing enzyme A20, an important negative regulator of NF-kB
signaling (Hymowitz and Wertz, 2010), and OTUB1, a proteinee also Figure S6G.
emm et al., 2010).
to free Lys48- and Lys63-polyUb.
amediated purification of TNF-RSC from human embryonic kidney 293T cells.
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with roles in the DNA damage response (Nakada et al., 2010).
Both enzymes prefer Lys48-linked polyUb, but it is not clear
whether this linkage specificity is relevant for their function. Cur-
rent models require A20 to hydrolyze Lys63 linkages (Hymowitz
and Wertz, 2010), whereas OTUB1 was shown to have noncata-
lytic functions by acting as a cellular buffer for charged E2 en-
zymes (Nakada et al., 2010). Particularly for A20, the low activity
for the OTUdomain suggests that, for example, posttranslational
modifications or one of the Ub-binding A20-interacting proteins
(Hymowitz and Wertz, 2010) could modulate its activity and/or
specificity.
An interesting observation is the specificity observed for
OTUD2 and VCPIP. Both enzymes efficiently cleave Lys11-
linked chains and interact with p97 (Ernst et al., 2009; Wang
et al., 2004), suggesting that p97 may act on substrates contain-
ing atypical linkage types, although the role of DUBs in p97 func-
tion is not well understood (Tsai and Weissman, 2011). The
similar specificity of OTUD2 and OTUD6A, another unstudied
OTU DUB, may suggest functional similarities. An additional
enzyme worth studying is OTUD3, given that it is, so far, the
only DUB that cleaves Lys6-linked diUb with some degree
of specificity. Lys6-linked polyUb is an enigmatic chain type
for which cellular roles are currently unclear (Kulathu and
Komander, 2012). Understanding the relevant interactions of
OTU DUBs (Sowa et al., 2009) may indicate physiological func-
tions for unstudied atypical Ub chain types.
OTUs as Tools in Ub Chain Research
We are excited by the prospects of Ub chain restriction analysis
in which linkage-specific OTU DUBs are used in vitro to reveal
the identity of the Ub chain type(s) on proteins, and we have
recently reported that they are useful reagents to interrogate
chain architecture in heterotypic chains (Hospenthal et al.,
2013). However, there are several caveats. The amount of poly-
ubiquitinated substrate is often unclear, especially in western
blotting applications. Also, the length, complexity, and number
of Ub chains on in vitro generated polyubiquitinated proteins
are often unknown. Therefore, each application of restriction
analysis requires careful titration of each DUB to prevent off-
target reactions. This is exaggeratedwhenDUB activity depends
on chain length (as seen for OTUD2). Furthermore, it is currently
unclear whether OTU DUBs can hydrolyze the first Ub linkage
(between substrate and proximal Ub) and how OTU DUBs deal
with branched polyUb (in which one Ub is modified at two or
more Lys residues, generating a forked structure). OTUB1 and
OTUD3 hydrolyze heterotypic (mixed and branched) and homo-
typic chains equally well (Hospenthal et al., 2013; Nakasone
et al., 2013).
Although some OTU DUBs seem remarkably specific (OTUB1
does not hydrolyze Lys6 linkages, even at high concentration in
overnight reactions) (Hospenthal et al., 2013), the small OTUD
family enzymes will cleave any linkage type when used at high
concentrations or over long time courses. With a deeper under-
standing of OTU DUB mechanisms, specificity, and additional
structural insights, efforts to ‘‘design’’ specificity in OTU DUBs
may generate enzymes with improved specificity and activity.
The use of Ub chain restriction analysis is not limited to OTU
DUBs—other DUB families, in particular the Lys63-specific182 Cell 154, 169–184, July 3, 2013 ª2013 The AuthorsJAMM enzymes, could be excellent additional tools for these
purposes.
In addition to Ub chain restriction analysis, there are several
other ways linkage-specific OTU DUBs could be exploited;
e.g., in mass-spectrometric applications to reveal proteins in
lysates harboring particular chains types or when inactivated
DUBs are used as linkage-specific UBDs to enrich certain link-
age types. Clearly, OTU family DUBs will continue to be valuable
tools in understanding the complex biology of protein ubiquitina-
tion events.
EXPERIMENTAL PROCEDURES
Cloning, Expression, and Purification of OTU DUBs
cDNAs for OTU DUBs were obtained from the IMAGE consortium by amplifi-
cation from human cDNA libraries or as a gift from kind colleagues. Constructs
according to Figure 1C were expressed in E. coli from pOPIN-K vectors and
purified by affinity chromatography, anion exchange, and gel filtration.
Modification of OTU DUBs by Suicide Probes
Ub-PA was generated as described in Ekkebus et al. (2013) and Ub-, NEDD8-,
and ISG15-derived haloalkyl probes were generated according to Akutsu et al.
(2011) and Borodovsky et al. (2002). DUB reactivity assays were performed at
room temperature for 1 hr (Ub-PA), 3 hr (haloalkyl probes), or as indicated.
In Vitro DUB Assays
Qualitative in vitro DUB linkage specificity assays were performed as in
Licchesi et al. (2012).
Crystallization and Structure Determination
Crystallization screening was performed in a sitting drop setup with com-
mercial screens. Structures were determined by molecular replacement (see
Table S1).
Fluorescence Polarization DUB Assay
Ub-based fluorescence polarization substrates were used as previously
described (Geurink et al., 2012).
Ub Chain Restriction Analysis
DUBs were diluted to 23 indicated concentrations, mixed with substrate, and
incubated for 15 min at 37C. Reactions were stopped by adding 43 lithium
dodecyl sulfate sample buffer, resolved on 4%–12% SDS-PAGE gradient
gels, and analyzed by silver staining and/or western blotting. Protocols for
the generation of model substrates are described in detail in the Extended
Experimental Procedures.
ACCESSION NUMBERS
Coordinates and structure factors have been deposited with the Protein Data
Bank under the following accession numbers: OTUD1, 4BOP; OTUD2, 4BOQ;
OTUD3, 4BOU; OTUD2-Lys11-diUb, 4BOZ; and OTUD2 UbK11 peptide,
4BOS.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, six
figures, one data set, and one table and can be found with this article online
at http://dx.doi.org/10.1016/j.cell.2013.05.046.
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